Latest stories on ATTO
Attovia Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Attovia Therapeutics to Participate in Upcoming Investor Conferences
StockTitan55 · neutralgeneral
Attovia Therapeutics, Inc. (ATTO) files 8-K
SEC 8-K50 · neutralgeneral
Attovia reports Q2 EPS ($4.88), consensus ($4.61)
The Fly59 · neutralearnings
Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
Business Insider63 · neutralproduct/pr
Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
GlobeNewswire59 · neutralproduct/pr
Wall Street analysts bullish on Attovia as itch drug data fuel biotech optimism
Investing.com Markets63 · neutralanalyst
Attovia initiated with an Outperform at Leerink
The Fly61 · neutralanalyst
Attovia initiated with an Outperform at LifeSci Capital
The Fly61 · neutralanalyst
Attovia initiated with a Buy at Citi
The Fly61 · neutralanalyst
Attovia initiated with an Overweight at Morgan Stanley
The Fly61 · neutralanalyst
RBC initiates Attovia stock with Outperform on IL-31 drug potential
Investing.com Analyst Ratings61 · neutralanalyst
Morgan Stanley initiates Attovia stock with overweight rating
Investing.com Analyst Ratings61 · neutralanalyst
Attovia initiated with an Outperform at RBC Capital
The Fly61 · neutralanalyst
Meet Attovia: The Clinical-Stage Biotech That Aims to Stop Chronic Itch at the Source
Yahoo Finance63 · neutralproduct/pr
Attovia adopts new charter and bylaws post-IPO
TipRanks50 · neutralgeneral
Attovia Therapeutics, Inc. (ATTO) files 8-K
SEC 8-K50 · neutralgeneral
Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq
StockTitan56 · neutralgeneral
Attovia Therapeutics shares jump 24% in trading debut after IPO
Investing.com Markets76 · bullishearnings
Biotech Attovia Therapeutics Climbs 24% After $289 Million IPO
Bloomberg68 · bullishearnings
Attovia Therapeutics prices upsized IPO at $17 per share, targets $289M raise
Seeking Alpha24 · bearishgeneral
Attovia Therapeutics prices IPO at $17 per share on Nasdaq
Investing.com Markets28 · bearishgeneral
Attovia Therapeutics Announces Pricing of Upsized Initial Public Offering
Business Insider24 · bearishgeneral
Goldman Sachs-backed Attovia eyes $731.5 million valuation in upsized US IPO
Reuters58 · neutralgeneral